70.25
price up icon0.95%   0.66
pre-market  Pre-market:  68.51   -1.74   -2.48%
loading
Praxis Precision Medicines Inc stock is traded at $70.25, with a volume of 205.04K. It is up +0.95% in the last 24 hours and down -2.94% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
See More
Previous Close:
$69.59
Open:
$69.77
24h Volume:
205.04K
Relative Volume:
0.64
Market Cap:
$1.31B
Revenue:
$1.77M
Net Income/Loss:
$-123.74M
P/E Ratio:
-7.6609
EPS:
-9.17
Net Cash Flow:
$-95.21M
1W Performance:
-4.66%
1M Performance:
-2.94%
6M Performance:
+32.25%
1Y Performance:
+70.72%
1-Day Range:
Value
$68.01
$70.52
1-Week Range:
Value
$60.07
$72.52
52-Week Range:
Value
$33.01
$86.93

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
Name
Praxis Precision Medicines Inc
Name
Phone
617-300-8460
Name
Address
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
Employee
82
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PRAX's Discussions on Twitter

Compare PRAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PRAX
Praxis Precision Medicines Inc
70.25 1.31B 1.77M -123.74M -95.21M -9.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.96 107.38B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
693.23 76.18B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
659.81 39.45B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
249.16 32.14B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
112.76 27.03B 3.30B -501.07M 1.03B -2.1146

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-05-24 Initiated Oppenheimer Outperform
Jun-24-24 Initiated Needham Buy
Jun-18-24 Initiated Guggenheim Buy
May-01-24 Initiated Robert W. Baird Outperform
Sep-19-23 Initiated Truist Buy
Jun-06-22 Downgrade Wedbush Outperform → Neutral
Dec-16-21 Initiated H.C. Wainwright Buy
Aug-26-21 Initiated BofA Securities Buy
Apr-26-21 Initiated William Blair Outperform
Nov-11-20 Initiated Wedbush Outperform
Nov-10-20 Initiated Cowen Outperform
Nov-10-20 Initiated Evercore ISI Outperform
Nov-10-20 Initiated Piper Sandler Overweight
View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

pulisher
Jan 12, 2025

Praxis Precision Medicines Unveils Ambitious 2025 Strategy: 4 Pivotal Trial Readouts, $470M Cash Runway - StockTitan

Jan 12, 2025
pulisher
Jan 12, 2025

Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities - The Bakersfield Californian

Jan 12, 2025
pulisher
Jan 10, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 8.9%Here's Why - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

(PRAX) Trading Report - Stock Traders Daily

Jan 09, 2025
pulisher
Jan 06, 2025

Praxis Precision Medicines to Present at J.P. Morgan Healthcare Conference - The Manila Times

Jan 06, 2025
pulisher
Jan 04, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $146.33 Consensus Price Target from Analysts - MarketBeat

Jan 04, 2025
pulisher
Jan 04, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jan 04, 2025
pulisher
Dec 29, 2024

Long Term Trading Analysis for (PRAX) - Stock Traders Daily

Dec 29, 2024
pulisher
Dec 28, 2024

Geode Capital Management LLC Has $22.95 Million Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Dec 28, 2024
pulisher
Dec 27, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by Barclays PLC - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Acquired by Barclays PLC - MarketBeat

Dec 27, 2024
pulisher
Dec 26, 2024

Praxis Precision Medicines: Multiple Potential Drivers (NASDAQ:PRAX) - Seeking Alpha

Dec 26, 2024
pulisher
Dec 25, 2024

Praxis Precision Medicines Inc (NASDAQ: PRAX) Stock Sentiment: What’s Wall Street Saying? - Stocks Register

Dec 25, 2024
pulisher
Dec 20, 2024

Franklin Resources Inc. Grows Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

State Street Corp Has $45.44 Million Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $913,000 Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Dec 19, 2024
pulisher
Dec 18, 2024

(PRAX) Technical Data - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 18, 2024

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine - The Bakersfield Californian

Dec 18, 2024
pulisher
Dec 18, 2024

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome - GlobeNewswire

Dec 18, 2024
pulisher
Dec 18, 2024

Praxis Precision Medicines Secures Key FDA Designation for Promising Epilepsy Drug Relutrigine - StockTitan

Dec 18, 2024
pulisher
Dec 16, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Sees Large Volume IncreaseHere's What Happened - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Wellington Management Group LLP Buys 168,394 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Praxis Precision Medicines’ (PRAX) Buy Rating Reiterated at HC Wainwright - Defense World

Dec 15, 2024
pulisher
Dec 14, 2024

BNP Paribas Financial Markets Has $548,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Dec 14, 2024
pulisher
Dec 14, 2024

BNP Paribas Financial Markets Purchases 7,496 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Here's Why We're Not Too Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Situation - Simply Wall St

Dec 13, 2024
pulisher
Dec 12, 2024

HC Wainwright Reaffirms "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat

Dec 12, 2024
pulisher
Dec 12, 2024

Expert Ratings For Praxis Precision Medicine - Benzinga

Dec 12, 2024
pulisher
Dec 11, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Trims Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 11, 2024
pulisher
Dec 11, 2024

Jefferies highlights Praxis Medicines as a 'top idea' for 2025, raises price target - Investing.com

Dec 11, 2024
pulisher
Dec 10, 2024

The Manufacturers Life Insurance Company Reduces Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Dec 10, 2024
pulisher
Dec 10, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 10, 2024
pulisher
Dec 08, 2024

Where are the Opportunities in (PRAX) - Stock Traders Daily

Dec 08, 2024
pulisher
Dec 08, 2024

Jacobs Levy Equity Management Inc. Cuts Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 08, 2024
pulisher
Dec 07, 2024

Janus Henderson Group PLC Purchases 141,881 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 07, 2024
pulisher
Dec 05, 2024

Praxis Precision management to meet with Oppenheimer - Nasdaq

Dec 05, 2024
pulisher
Dec 05, 2024

RA Capital Management L.P. Has $43.84 Million Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 05, 2024
pulisher
Dec 03, 2024

HighVista Strategies LLC Makes New $630,000 Investment in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Praxis Precision Medicines to Present at Upcoming December Investor Conferences - The Manila Times

Dec 03, 2024
pulisher
Dec 03, 2024

Praxis Precision Medicines to Present at Major Healthcare Investor Conferences in December - StockTitan

Dec 03, 2024
pulisher
Dec 03, 2024

Walleye Capital LLC Buys New Shares in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Baker BROS. Advisors LP Has $18.59 Million Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Fred Alger Management LLC Buys 7,828 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

PRAX (Praxis Precision Medicines) Shares Outstanding (EOP) : 17.79 Mil (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Nov 30, 2024

Verition Fund Management LLC Lowers Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Nov 30, 2024
pulisher
Nov 28, 2024

PRAX (Praxis Precision Medicines) Debt-to-EBITDA : -0.01 (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 28, 2024

Ally Bridge Group NY LLC Sells 80,194 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Acuta Capital Partners LLC - MarketBeat

Nov 28, 2024
pulisher
Nov 26, 2024

Praxis Precision Medicines to Showcase Updates from Largest - GlobeNewswire

Nov 26, 2024
pulisher
Nov 26, 2024

Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting - The Manila Times

Nov 26, 2024

Praxis Precision Medicines Inc Stock (PRAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.22
price up icon 4.89%
$30.95
price up icon 0.68%
$72.47
price up icon 0.01%
$366.39
price up icon 1.31%
biotechnology ONC
$205.34
price up icon 1.79%
$112.76
price down icon 0.80%
Cap:     |  Volume (24h):